FAM44 Antibodies

Santa Cruz Biotechnology features a diverse variety of FAM44 monoclonal antibodies for research applications. FAM44 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FAM44, or Family with Sequence Similarity 44, plays a significant role in cellular processes, including cell cycle regulation and apoptosis. Understanding FAM44 function is essential for investigating various diseases, particularly cancer development and progression. FAM44 research continues to reveal new insights into cellular signaling pathways and their impact on disease mechanisms. Studying FAM44 enables scientists to explore potential therapeutic approaches for cancer treatment. Research focusing on FAM44 has expanded our understanding of cell cycle control and programmed cell death. Ongoing investigations of FAM44 contribute to developing novel treatment strategies. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge and developing innovative therapeutic approaches.